Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reactogenicity, Safety and Immunogenicity of a TB/FLU-04L Tuberculosis Vaccine

NCT02501421 is registered in ClinicalTrials.gov with Research Institute for Biological Safety Problems as lead sponsor.

NCT NCT02501421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02501421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reactogenicity, Safety and Immunogenicity of a TB/FLU-04L Tuberculosis Vaccine
Lead sponsor
Research Institute for Biological Safety Problems
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2013
Completion date
February 28, 2015
Enrollment
44 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis